Shares of Seattle Genetics fell 2.52% to $186.00 at 12:45 EST on Thursday, after three sequential sessions in a row of gains. NASDAQ Composite is rising 0.21% to $13,485.79, after two sequential sessions in a row of gains. This seems, up until now, a somewhat positive trend trading session today.
Seattle Genetics’s last close was $190.80, 15.02% below its 52-week high of $213.94.
Seattle Genetics’s Sales
Seattle Genetics’s sales growth is 101.2% for the present quarter and 60.8% for the next. The company’s growth estimates for the ongoing quarter and the next is 500% and 72.4%, respectively.
Seattle Genetics’s Revenue
Year-on-year quarterly revenue growth grew by 397.9%, now sitting on 1.86B for the twelve trailing months.
Seattle Genetics’s last day, last week, and last month’s average volatility was a positive 1.07%, a positive 1.15%, and a negative 0.17%, respectively.
Seattle Genetics’s last day, last week, and last month’s high and low average amplitude percentage was 2.85%, 2.92%, and 3.18%, respectively.
Seattle Genetics’s Stock Yearly Top and Bottom Value
Seattle Genetics’s stock is valued at $186.00 at 12:45 EST, way under its 52-week high of $213.94 and way above its 52-week low of $90.57.
Seattle Genetics’s Moving Average
Seattle Genetics’s worth is higher than its 50-day moving average of $184.50 and above its 200-day moving average of $177.14.